Skip to main content
    R

    Rani Therapeutics Holdings Inc (RANI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.54
    +0.01 (+2.66%)

    Market Cap: $60.78M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Rani Therapeutics Holdings Inc (RANI) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Rani Therapeutics Holdings are Rein Therapeutics (RNTX), Vivani Medical (VANI) and Serina Therapeutics (SER). By market cap, Rani Therapeutics Holdings ranks 8th of the 13 companies on this page; NRX Pharmaceuticals (NRXP) is the largest at $95.58M.

    Peer Comparison

    RANI's revenue growth of 893.0% is above the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Rani Therapeutics Holdings (RANI)$60.78MN/A16.3x0.0%N/A893.0%0.00%
    Rein Therapeutics Inc (RNTX)$47.63MN/AN/A0.0%N/A0.0%0.00%
    Vivani Medical Inc. (VANI)$91.11MN/AN/A0.0%N/A0.0%0.00%
    Serina Therapeutics Inc (SER)$36.93MN/A288.7x0.0%-109.4%154.9%0.00%
    Tenaya Therapeutics Inc (TNYA)$79.59MN/AN/A0.0%N/A0.0%0.00%
    NRX Pharmaceuticals Inc (NRXP)$95.58MN/A23.8x0.0%N/A0.0%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    Rallybio Corp (RLYB)$88.03MN/A203.1x6177.0%N/A0.0%0.00%
    RenovoRx Inc (RNXT)$50.18MN/A16.6x0.0%N/A300.8%0.00%
    Actinium Pharmaceuticals Inc (ATNM)$51.56M4.1x1.3x32.2%N/A-100.0%0.00%
    vTv Therapeutics Inc (VTVT)$78.99MN/AN/A-20.8%N/A0.0%0.00%
    Nutriband Inc (NTRB)$74.15MN/A43.7x0.0%-101.3%-29.7%0.00%
    MAIA Biotechnology Inc. (MAIA)$61.75MN/AN/A0.0%N/A0.0%0.00%
    Peer median$67.95M4.1x33.8x0.0%-109.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Rani Therapeutics Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Rein Therapeutics Inc (RNTX)
    Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders...
    RNTX competitors
    Vivani Medical Inc. (VANI)
    Vivani Medical Inc. (VANI) is a pioneering biotechnology firm focused on revolutionizing chronic disease management through its cutting-edge drug delivery...
    VANI competitors
    Serina Therapeutics Inc (SER)
    Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology...
    SER competitors
    Tenaya Therapeutics Inc (TNYA)
    Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary...
    TNYA competitors
    NRX Pharmaceuticals Inc (NRXP)
    NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company...
    NRXP competitors
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    Rallybio Corp (RLYB)
    Rallybio Corp is a clinical-stage biotechnology company focused on developing innovative therapies for rare diseases...
    RLYB competitors
    RenovoRx Inc (RNXT)
    RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors.
    RNXT competitors
    Actinium Pharmaceuticals Inc (ATNM)
    Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation...
    ATNM competitors
    vTv Therapeutics Inc (VTVT)
    vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet...
    VTVT competitors
    Nutriband Inc (NTRB)
    Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida.
    NTRB competitors
    MAIA Biotechnology Inc. (MAIA)
    MAIA Biotechnology Inc. is an innovative biotechnology company focused on developing cutting-edge cancer therapies that significantly improve patient outcomes...
    MAIA competitors

    Frequently Asked Questions About RANI

    Who are Rani Therapeutics Holdings' main competitors?

    The companies most similar to Rani Therapeutics Holdings include Rein Therapeutics (RNTX), Vivani Medical (VANI), Serina Therapeutics (SER), Tenaya Therapeutics (TNYA) and NRX Pharmaceuticals (NRXP), listed from the closest match.

    Who is Rani Therapeutics Holdings' biggest competitor?

    NRX Pharmaceuticals (NRXP) is the largest of the similar companies at $95.58M; Rein Therapeutics (RNTX) is the closest match by business profile, size, sector and industry.

    How does RANI stock compare with its competitors?

    RANI's P/S is 16.3x against a peer median of 33.8x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Rani Therapeutics Holdings' competitors pays a higher dividend?

    Rani Therapeutics Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Rani Therapeutics Holdings bigger than its competitors?

    No. Rani Therapeutics Holdings is 8th by market cap among the 13 companies on this page; the largest is NRX Pharmaceuticals (NRXP) at $95.58M.